Biogen, Inc. (BIIB)
177.34
-6.44
(-3.50%)
USD |
NASDAQ |
Apr 02, 16:00
177.32
-0.02
(-0.01%)
After-Hours: 20:00
Biogen SG&A Expense (TTM) : 2.434B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 7.05B |
| Gilead Sciences, Inc. | 8.398B |
| Eli Lilly & Co. | 11.09B |
| Merck & Co., Inc. | 10.73B |
| Apellis Pharmaceuticals, Inc. | 550.26M |